Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance

References

• Qu M, Zeng R, Long J, et al. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Int J Pharm. 2014;474:112–122.
   PubMed Web of Science ®Google Scholar
• Sun TM, Du JZ, Yao YD, et al. Simultaneous delivery of siRNA and paclitaxel via a two- in-one micelleplex promotes synergistic tumor suppression. ACS Nano. 2011;5:1483–1494.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Yook S, Yhee JY, et al. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo. J Control Release. 2015;220:631–641.
   PubMed Web of Science ®Google Scholar
• Kaps L, Nuhn L, Aslam M, et al. In vivo gene-silencing in fibrotic liver by siRNA-loaded cationic nanohydrogel particles. Adv Healthc Mater. 2015;4:2809–2815.
   PubMed Web of Science ®Google Scholar
• Devi GR. SiRNA-based approaches in cancer therapy. Cancer Gene Ther. 2006;13:819–829.
   PubMed Web of Science ®Google Scholar
• Lee JB, Hong J, Bonner DK, et al. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater. 2012;11:316–322.
   PubMed Web of Science ®Google Scholar
• Hart SL. Multifunctional nanocomplexes for gene transfer and gene therapy. Cell Biol Toxicol. 2010;26:69–81.
   PubMed Web of Science ®Google Scholar
• Mastrobattista E, van der Aa MA, Hennink WE, et al. Artifical viruses:a nanotechnological approach to gene delivery. Nat Rev. 2006;5:115–121.
   Google Scholar
• Kogure K, Akita H, Harashima H. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of programmed packaging. J Control Release. 2007;122:246–251.
   PubMed Web of Science ®Google Scholar
• Kogure K, Akita H, Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev. 2008;60:559–571.
   PubMed Web of Science ®Google Scholar
• Hu YH, Atukorale PU, Lu JJ, et al. Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or sirna cargos to pH-responsive core-shell gel particles. Biomacromolecules. 2009;10:756–765.
   PubMed Web of Science ®Google Scholar
• Zhou JH, Wu YD, Wang CR, et al. pH-sensitive nanomicelles for high-efficiency siRNA delivery in vitro and in vivo: an insight into the design of polycations with robust cytosolic release. Nano Lett. 2016;16:6916–6923.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Du LL, Meng LW, et al. The promising nanocarrier for doxorubicin and siRNA co-delivery by PDMAEMA-based amphiphilic nanomicelles. ACS Appl Mater Interfaces. 2016;8:4347–4356.
   PubMed Web of Science ®Google Scholar
• Boyer C, Priyanto P, Davis TP, et al. Anti-fouling magnetic nanoparticles for siRNA delivery. J Mater Chem. 2010;20:255–265.
   Web of Science ®Google Scholar
• Xu FJ, Chai MY, Li WB, et al. Well-defined poly(2-hydroxyl-3-(2-hydroxyethylamino)propyl methacrylate) vectors with low toxicity and high gene transfection efficiency. Biomacromolecules. 2010;11:1437–1442.
   PubMed Web of Science ®Google Scholar
• Jere D, Xu CX, Arote R, et al. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells. Biomaterials. 2008;29:2535–2547.
   PubMed Web of Science ®Google Scholar
• Reddy TL, Garikapati KR, Reddy SG, et al. Simultaneous delivery of paclitaxel and Bcl-2 siRNA via pH-sensitive liposomal nanocarrier for the synergistic treatment of melanoma. Sci Rep. 2016;6:35223.
   PubMed Web of Science ®Google Scholar
• Wu D, Yang JB, Xing Z, et al. Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation. Colloids Surf B Biointerfaces. 2016;146:318–325.
   PubMed Web of Science ®Google Scholar
• Liu XY, Li LJ, Li J, et al. Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp. Oncol Rep. 2016;35:3018–3024.
   PubMed Web of Science ®Google Scholar
• Kumar V, Ahmed D, Anwar F, et al. Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2(I) → 1(II))-α-D-glucopyranoside in streptozotocin induced diabetic rats. Springerplus. 2013;2:639.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Akita H, Harashima H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. 2007;14:68–77.
   PubMed Web of Science ®Google Scholar
• He ZL, Huang JW, Xu YY, et al. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. Oncotarget. 2015;6:42150–42168.
   PubMed Web of Science ®Google Scholar
• Jin GM, Jin MJ, Yin XZ, et al. A comparative study on the effect of docetaxel-albumin nanoparticles and docetaxel-loaded PEG-albumin nanoparticles against non-small cell lung cancer. Int J Oncol. 2015;47:1945–1953.
   PubMed Web of Science ®Google Scholar
• Guk K, Lim H, Kim B, et al. Acid-cleavable ketal containing poly(β-amino ester) for enhanced siRNA delivery. Int J Pharm. 2013;453:541–550.
   PubMedGoogle Scholar
• Sankaranarayanan J, Mahmoud EA, Kim G, et al. Multiresponse strategies to modulate burst degradation and release from nanoparticles. ACS Nano. 2010;4:5930–5936.
   PubMed Web of Science ®Google Scholar
• Shah SM, Goel PN, Jain AS, et al. Liposomes for targeting hepatocellular carcinoma: Use of conjugated arabinogalactan as targeting ligand. Int J Pharm. 2014;477:128–139.
   PubMed Web of Science ®Google Scholar
• Ashley JD, Stefanick JF, Schroeder VA, et al. Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo. J Control Release. 2014;196:113–121.
   PubMed Web of Science ®Google Scholar
• Park J, Reddy Kadasala N, Abouelmagd SA, et al. Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. Biomaterials. 2016;101:285–295.
   PubMed Web of Science ®Google Scholar
• Theek B, Baues M, Ojha T, et al. Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. J Control Release. 2016;231:77–85.
   PubMed Web of Science ®Google Scholar
• Attia ABE, Oh P, Yang C, et al. Insights into EPR effect versus lectin-mediated targeted delivery: biodegradable polycarbonate micellar nanoparticles with and without galactose surface decoration. Small. 2014;10:4281–4286.
   PubMed Web of Science ®Google Scholar
• Lee BS, Yip AT, Thach AV, et al. The targeted delivery of doxorubicin with transferrin-conjugated block copolypeptide vesicles. Int J Pharm. 2015;496:903–911.
   PubMedGoogle Scholar
• Gabizon A, Catane R, Uziely B, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes. Cancer Res. 1994;54:987–992.
   PubMed Web of Science ®Google Scholar
• Arranja A, Schroder AP, Schmutz M, et al. Cytotoxicity and internalization of pluronic micelles stabilized by core cross-linking. J Control Release. 2014;196:87–95.
   PubMed Web of Science ®Google Scholar